Background--Metabolic disorders with visceral obesity have become a major medical problem associated with the development of hypertension, type 2 diabetes, and dyslipidemia and, ultimately, life-threatening cardiovascular and renal diseases. Adipose tissue dysfunction has been proposed as the cause of visceral obesity-related metabolic disorders, moving the tissue toward a proinflammatory phenotype.
P resently, patients with metabolic disorders with visceral obesity are increasing worldwide. One common metabolic phenotypic change is reported to be systemic insulin resistance, and the chronic activation of an inflammatory response in adipose tissue is suggested to contribute to the development of systemic insulin resistance in visceral obesity. [1] [2] [3] However, the pathological molecular mechanisms involved in the interplay between the chronic inflammation of adipose tissue and metabolic disorders with visceral obesity have not been fully elucidated, and it is critically important to generate model mice with human-like metabolic syndrome, which is principally provoked by environmental factors such as dietary high caloric loading. The excessive activation of the renin-angiotensin system (RAS), a system that regulates both cardiovascular and body fluid homeostasis, has been implicated in the development of obesity-related metabolic disorders, such as type 2 diabetes mellitus (T2DM), hypertension, and dyslipidemia. 4, 5 At local tissue sites, RAS acts through the production of the bioactive molecule angiotensin II (Ang II), and the Ang II type 1 receptor (AT1R) is the main receptor subtype. We have previously identified the AT1R-associated protein (ATRAP/ Agtrap) as a directly interacting molecule with the carboxyl-terminal domain of AT1R, 6, 7 and previous studies showed that ATRAP promotes constitutive internalization of the AT1R so as to inhibit the pathological activation of its downstream signaling but preserve physiological signaling activity. [8] [9] [10] [11] In the present study, we showed that both patients and mice with metabolic disorders exhibited decreases in the adipose expression of ATRAP without any significant changes in adipose AT1R expression. In addition, animals with a genetic disruption of the Agtrap gene displayed a largely normal physiological phenotype under standard diet but developed metabolic disorders on dietary high fat (HF) loading. Together with the metabolic functional rescue by a transplantation of fat overexpressing ATRAP into Agtrap À/À mice, this result revealed that the suppression of ATRAP expression in local adipose tissue is critically involved in the development of metabolic disorders with visceral obesity. The results of these analyses suggest that Agtrap À/À mice can serve as a model of human metabolic syndrome induced by dietary loading and suggest a novel protective role of ATRAP in the pathogenesis of metabolic disorders with visceral obesity, and hence the therapeutic potential of ATRAP.
Materials and Methods
This study was performed in accordance with the National Institutes of Health (NIH) "Guide for the Care and Use of Laboratory Animals." All of the animal studies were reviewed and approved by the Animal Studies Committee of Yokohama City University. For gene expression analyses in human tissues, written informed consent was obtained from all patients, and the study was approved by the Human Ethics Review Committee of Yokohama City University Graduate School of Medicine.
Human Total RNA in Normal Tissues
We purchased commercially available normal human total RNAs from either Takara Bio Inc or Wako Pure Chemical for the analysis of ATRAP and AT1R mRNA expression in normal human tissues. According to the description in the instruction sheets of these purchased RNAs, total RNAs were extracted from normal tissues of the brain (No. R1234035-50; Wako Pure Chemical), heart (No. R1234122-50; Wako Pure Chemical), liver (No. 636531; Takara Bio Inc), fat (No. 636558; Takara Bio Inc), skeletal muscle (No. 636534; Takara Bio Inc), and kidney (No. R1234142-50; Wako Pure Chemical), which were derived from pooled donors. For example, with respect to human adipose tissues, total RNAs were derived from a variety of donors (n=18) pooled from male and female whites aged 21 to 61, whose cause of death was trauma or sudden death.
Visceral Adipose Tissues From Patients
Visceral adipose tissues from patients undergoing abdominal surgery, such as early-stage gastric or colon cancer, were obtained from 36 Japanese patients and used for the analysis of ATRAP and AT1R mRNA expression using a real-time quantitative RT-PCR method. Among the patients analyzed, the serum triglyceride level was measured in 28 patients (21 men and 7 women). Written informed consent was obtained from all patients, and this study was approved by the Human Ethics Review Committee of Yokohama City University Graduate School of Medicine.
Animals
The animals were housed in a controlled environment with a 12-hour light-dark cycle and were allowed free access to food and water. They were fed either a standard diet (SD, 3.6 kcal/g; 13.3% energy as fat; Oriental MF, Oriental Yeast Co, Ltd) or an HF diet (HFD, 5.6 kcal/g; 60.0% energy as fat) for 6 weeks beginning at 7 weeks of age. Body weight and food intake were recorded weekly throughout the experimental period. In the KKA y mice study, male KKA y mice were purchased from Clea Japan. This study was performed in accordance with the NIH guidelines for the use of experimental animals. All of the animal studies were reviewed and approved by the Animal Studies Committee of Yokohama City University.
Targeted Disruption of the Gene Encoding ATRAP/Agtrap in C57BL6 Mice
To construct the targeting vector for disruption of the Agtrap gene, a neomycin resistance gene was substituted for exons 3, 4, and 5 in the coding region of the Agtrap gene ( Figure 1A ). The vector contained 4.6-kb 5′ and 4.7-kb 3′ homology arms. At the 5′ terminus of the homologous region, the phosphoglycerate kinase 1-thymidine kinase gene was inserted to negatively select for random integrations. The Agtrap targeting vector was linearized and electroporated into RENKA (C57BL/6) embryonic stem cells, and G418-resistant clones were screened for homologous recombination by Southern blot analysis ( Figure 1B ). Eleven independent cell lines of 288 G418-resistant cells underwent homologous recombination at the Agtrap locus. Chimeric mice were generated by injecting these positive clones into ICR 8-cell embryos, and 1 clone gave rise to germline transmission. After confirmation of the transmission of the mutations into germ cells, the heterozygous mice were intercrossed to produce homozygous offspring, and mutation at the Agtrap locus was identified by Southern blot analysis, using probe A of the tail DNA from the F1 offspring ( Figure 1C ). Heterozygous mice were backcrossed with C57BL/6 for 2 generations and then intercrossed (hetero9hetero) to obtain homozygous Agtrap À/À mice, a result that was confirmed by 
Blood Pressure Measurement
Systolic blood pressure was measured noninvasively by the tail-cuff method (MK-2000 BP monitor; Muromachi Kikai Co). The MK-2000 BP monitor made it possible to measure blood pressure without preheating the animals and anesthesia, thus avoiding very stressful condition. 12 At least 8 readings were taken for each measurement.
Histological Analysis
The epididymal white adipose tissue was isolated and fixed with 10% paraformaldehyde overnight and embedded in paraffin. Tissue sections were stained with hematoxylin and eosin for cell size determination. Paraffin sections of white adipose tissue were also stained with an antibody against F4/80 (rat monoclonal; Abcam). Briefly, antigen retrieval was performed by microwave heating and endogenous reactive molecules were quenched by peroxidase blocking reagent (DAKO). Then, the sections were incubated with monoclonal anti-F4/80 antibody (diluted 1:10) at room temperature for 2 hours, followed by Histofine Simple Stain Max PO (Nichirei Bioscience Inc). Antibody binding was visualized with 3,3 0 -diaminobenzidine (DAB) using a detection kit (Nichirei Bioscience Inc), and all sections were counterstained with hematoxylin. The adipocyte diameter and area were quantified using Image-Pro Plus software, and F4/80-positive nuclei were counted in low-powered fields.
Fat Transplantation
In the fat transplantation experiments, 13 6-week-old male Agtrap À/À mice were used as recipients. Donor epididymal fat pads were removed from sex-matched Agtrap À/À , WT Agtrap
, or Agtrap transgenic (Tg19) mice (6 to 11 weeks of age). The generation and characterization of Agtrap transgenic (Tg64 and Tg19) mice carrying the hemagglutinin (HA)-tagged mouse ATRAP cDNA have been described previously.
14 The donor fat pads were cut into 100-to 200-mg pieces and kept in saline until transplantation. Small incisions were made on the back of each anesthetized recipient mouse, and a total of 900 mg of fat pad tissue (5 pieces of the donor fat pads 3 cm apart from one another) was implanted subcutaneously (ie, below the skin on the back of recipient mouse). One week after transplantation surgery, the recipient mice were fed an HF diet (5.6 kcal/g; 60.0% energy as fat; Oriental MF, Oriental Yeast Co Ltd) for 6 weeks, and the endogenous epididymal adipose tissues of the recipient mice were harvested for analysis of adipose tissue weight.
Real-time Quantitative RT-PCR Analysis
Total RNA was extracted from epididymal adipose tissue with ISOGEN (Nippon Gene), and cDNA was synthesized using the SuperScript III First-Strand System (Invitrogen). Real-time quantitative RT-PCR was performed with an ABI PRISM 7000 Sequence Detection System by incubating the reverse transcription product with TaqMan PCR Master Mix and a designed Taqman probe (Applied Biosystems), essentially as described previously. 15 The mRNA levels were normalized to those of the 18S rRNA control. The primer sequences used are shown in Table 1 .
Immunoblot Analysis
A 14-amino acid synthetic peptide corresponding to amino acids 148 to 161 of the carboxyl-terminal tail of mouse (DBA/2J) ATRAP was used for the generation of a polyclonal anti-ATRAP antibody. 6 The characterization and specificity of the anti-ATRAP antibody were described previously. 14, 16, 17 For immunoblot analysis, the total protein was extracted from adipose tissues of Agtrap +/+ (WT) and
Agtrap transgenic (Tg64 and Tg19) mice with SDS-containing sample buffer, and the protein concentration of each sample was measured with a DC protein assay kit (Bio-Rad) using BSA as the standard. Equal amounts of protein extract from the tissue samples were fractionated on a polyacrylamide gel (ATTO), then transferred to a polyvinylidene difluoride (PVDF) membrane using the iBlot Dry Blotting System (Invitrogen). Membranes were blocked for 1 hour at room temperature with phosphate-buffered saline containing 5% skim milk powder and probed overnight at 4°C with the anti-ATRAP antibody diluted at 1:1000. Then, the membranes were washed and incubated with the anti-rabbit secondary antibody diluted at 1:300 for 40 minutes at room temperature. After they were washed, the sites of the antibody-antigen reaction were visualized by enhanced chemiluminescence substrate (GE Healthcare). The images were quantitated using a FUJI LAS3000 Image Analyzer (FUJI Film).
Statistical Analysis
All data are shown as meanAESEM. Differences were analyzed by Student's unpaired t test or ANOVA followed by the Newman-Keuls multiple-comparison test. Two-way ANOVA was used for analysis of data that are measured longitudinally from the same mouse. Kruskal-Wallis test with Dunn post-hoc test was used for analysis of small sample size. A P value of <0.05 was considered statistically significant.
Results

ATRAP Is Abundantly Expressed in Adipose Tissue but Decreased in Metabolic Disorders in Humans
Both ATRAP and AT1R mRNA were abundantly expressed in normal human adipose tissue from pooled donors (Figure 2A and 2B). To examine whether the dynamic balance of the endogenous expression of ATRAP and AT1R in adipose tissue is modulated in metabolic disorders in humans, visceral adipose tissues were obtained from 36 patients during abdominal surgery (Table 2) . We divided these patients into 2 groups using the 4 metabolic parameters (hypertension, obesity, diabetes, and hypertriglyceridemia) using the criteria of Japanese Society of Internal Medicine for the diagnosis of metabolic syndrome. 18 Interestingly, we found that the expression of ATRAP mRNA was significantly decreased in the adipose tissue from hypertensive patients compared with normotensive patients (0.55AE0.07 versus 1.00AE0.16, P=0.031; Figure 2C ). Similar trends of decrease in adipose ATRAP mRNA expression were observed in patients with obesity and diabetes ( Figure 2C ). On the other hand, the adipose AT1R mRNA levels in patients with these metabolic disorders were the same as those in patients without respective metabolic disorders ( Figure 2D ).
ATRAP Expression in Adipose Tissue Is Decreased in Mice With Metabolic Dysfunction
To analyze metabolic disorder-related change in the balance of the endogenous expression of ATRAP and AT1R in the adipose tissue of mice as well, we examined ATRAP and AT1R gene expression in the adipose tissues from genetically obese diabetic KKA y mice, a model of T2DM without any dietary loading. Although the ATRAP mRNA was abundantly expressed in adipose tissue of the control C57BL6 mice ( Figure 3A) , the adipose ATRAP mRNA expression was significantly decreased in 13-week-old male KKA y mice compared with control mice (0.40AE0.02 versus 1.00AE0.07, P<0.0001; Figure 3B ). On the other hand, the adipose AT1R mRNA expression did not differ between KKA y mice and control mice ( Figure 3C ), which was consistent with the results observed in the adipose tissue of patients with metabolic disorders. The finding that adipose ATRAP expression was decreased in metabolic disorders both in humans and in diabetic mice prompted us to hypothesize that a decrease in ATRAP expression in local adipose tissue is involved in the pathogenesis of metabolic disorders with visceral obesity. Mice AT1R Mm00616371_m1
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ATRAP Deficiency Causes an Increase in Blood Pressure and Adipocyte Hypertrophy in Response to Dietary HF Loading
To examine the hypothesis that a decrease in adipose ATRAP expression is associated with the development of metabolic disorders, we next generated mice with mutations in Agtrap ( Figure 1A through 1C) . Agtrap À/À mice at baseline displayed no evident anatomical abnormality or alteration in physiological parameters (Table 3 ). This is in striking contrast to the genetic inactivation of other RAS components, such as angiotensinogen, rennin, and AT1R. These RAS-inactivated A ATRAP mRNA levels B (Table 3 and Figure 4A ), body weight, change in body weight, and food intake did not significantly differ between the 2 groups ( Figure 4A through 4C) . On the other hand, the epididymal fat weight of Agtrap À/À mice fed a HF diet was increased compared with that of their WT littermates, whereas there was no significant difference in mesenteric fat weight (Table 3) . With respect to the regulation of blood pressure, only Agtrap À/À mice exhibited a significant elevation of blood pressure on HF loading ( Figure 4D ).
ATRAP Deficiency Causes Insulin Resistance in Response to HF Loading
Since there was evident dietary HF loading-mediated enlargement of adipocytes in Agtrap À/À mice, we next examined the patterns of glucose and lipid metabolism, which are suggested to be closely associated with adipose tissue function, 23, 24 using blood samples obtained by cardiac puncture at the time mice were sacrificed ( Figure 5A ). Nonfasting blood glucose did not differ significantly between Agtrap À/À mice and WT Figure 5B ). These results support the conclusion that ATRAP deficiency is closely associated with insulin resistance.
ATRAP Deficiency Exacerbates Inflammatory Responses in Adipose Tissue in Response to HF Loading
We investigated possible changes in adipocytokine production and found that the HF loading-mediated upregulation of MCP-1, a key player in the inflammatory process, 25, 26 was exacerbated in the adipose tissue of Agtrap À/À mice compared with WT Agtrap +/+ mice ( Figure 6A ). On the other hand, the HF loading-mediated increase in IL-6 expression did not reach the statistical significance in the adipose tissue of Agtrap À/À mice and no significant changes were observed in TNFa or PAI-1. Because MCP-1 contributes to the macrophage recruitment in inflamed adipose tissue, we next examined macrophage-related gene expression and macrophage infiltration. We found that the expression patterns of CD68 and F4/80 were significantly elevated in the adipose tissue of Agtrap Figure 6B ). This finding is consistent with the upregulation of macrophage-specific genes (CD68, F4/80 in Figure 6A ) in the adipose tissue of Agtrap À/À mice. Collectively, these Transplantation of Fat Overexpressing ATRAP Improves Metabolic Dysfunction in ATRAP Deficiency Under HF Loading
As described here, the results of present study indicate that Agtrap À/À mice are an effective model of metabolic disorders with visceral obesity by dietary intervention and suggest a protective role of ATRAP against the pathogenesis of metabolic dysfunction. Thus, we hypothesized that physiological production and secretion of putative protective factors from normal adipose tissue may be impaired by the ATRAP deficiency so as to provoke systemic metabolic dysfunction. Therefore, we next performed a fat-transplantation strategy to examine our hypothesis. 13 We examined effects of transplantation of donor fat pads derived from Agtrap À/À mice, WT Agtrap +/+ mice and Agtrap transgenic mice (Tg19). The total adipose ATRAP protein expression detected by the anti-ATRAP antibody was significantly higher in Agtrap transgenic mice (Tg19) (endogenous ATRAP and transgene HA-ATRAP) than in Agtrap +/+ mice (WT) (endogenous ATRAP) ( Figure 7A ). Therefore, the donor fat pads derived from Agtrap transgenic mice (Tg19), which exhibited a 3.7-fold increase in ATRAP mRNA expression in epididymal adipose tissue compared with Agtrap +/+ mice (WT) ( Figure 7A ), were used to examine a possible beneficial effect of adipose-specific ATRAP activation on systemic metabolic We transplanted a total of 900 mg of the fat pad subcutaneously into Agtrap À/À recipient mice, which were then subjected to HF loading for 6 weeks. These fat grafts were successfully implanted and viable, as confirmed by histological analysis (Figure 7B and 7C) . After the HF loading, there was no significant difference in body weight among the 3 groups ( Figure 7D ). However, the weight of the endogenous epididymal adipose tissue in Agtrap À/À mice receiving the fat pad from the Agtrap transgenic mice (KO-Tg19) was markedly decreased compared with that of the animals receiving endogenous epididymal adipose tissue from Agtrap respectively; Figure 7E) With respect to possible mechanisms involved in the rescue of metabolic dysfunction in Agtrap À/À recipient mice by fat transplantation, the transplanted adipose tissue is likely to be functionally active to promote glucose uptake by the fat graft itself at the local site. However, despite the transplantation of fat overexpressing ATRAP into Agtrap À/À recipient mice, a considerable amount of the total adipose tissue mass remained ATRAP deficient. Thus, the transplanted adipose tissue overexpressing ATRAP may have some cell-autonomous properties with the capacity to release some protective factors that can act on other organs and tissues including the ATRAP-deficient adipose tissue to improve insulin sensitivity against metabolic dysfunction, but such protective factor was not identified yet in this study. A previous study that first reported and examined the effects of fat transplantation also showed that surgical implantation of adipose tissue successfully improved the muscle insulin sensitivity in lipoatrophic mice, thereby suggesting the metabolic and endocrine communication between adipose tissue and the rest of the body. 30 Therefore, although our findings of crosstalk specifically between fat graft and other adipose tissue are of considerable interest, the possible mechanisms need to be further elucidated. Taken together, we suggest that adipose tissue ATRAP plays a preventive role against the development of metabolic disorders with visceral obesity, provoked by pathological HF loading. Because ATRAP is highly expressed in adipose tissue of WT Agtrap +/+ mice, the development of systemic insulin resistance related to ATRAP deficiency is attributable to the exaggeration of adipose tissue inflammation in Agtrap À/À mice that occurs via the secretion of proinflammatory cytokines and factors derived from enlarged adipocytes. [1] [2] [3] 31, 32 However, as a limitation of the present study, even though the results of fat transplantation experiment would support the important protective role of adipose ATRAP against metabolic dysfunction, these results strictly do not rule out the secondary effects from other tissues. 30 In particular, since this is a systemic gene knockout model but not adipose tissue-specific gene knockout model, the function of ATRAP in other tissues, mainly in the cardiovascular and renal systems, can also contribute to the metabolic dysfunction observed in the Agtrap À/À mice. Thus, although our findings of crosstalk specifically between fat graft, liver, and other adipose tissue are of considerable interest, the possible mechanisms need to be further elucidated. In summary, the data obtained from this study demonstrated that ATRAP, a directly interacting and functionally inhibiting molecule of AT1R, plays a protective role against the development of systemic insulin resistance via regulatory effects on adipose tissue function. Adipose tissue ATRAP may therefore serve as a molecular target in metabolic disorders with visceral obesity. Characterization of the cellular and molecular mechanism of ATRAP regulatory adipose tissue function should have important cardiovascular pathophysiological and therapeutic implications.
